|
KIAA0495 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
1.85589998924485E-09 |
| Normal-vs-Stage3 |
7.7715611723761E-15 |
| Normal-vs-Stage4 |
7.75413067088948E-12 |
| Stage1-vs-Stage2 |
9.269400E-01 |
| Stage1-vs-Stage3 |
1.877810E-01 |
| Stage1-vs-Stage4 |
3.516200E-01 |
| Stage2-vs-Stage3 |
3.735200E-01 |
| Stage2-vs-Stage4 |
4.615400E-01 |
| Stage3-vs-Stage4 |
9.369600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
7.96770000000002E-05 |
| Normal-vs-Asian |
1.33510003053061E-09 |
| Caucasian-vs-AfricanAmerican |
3.616000E-01 |
| Caucasian-vs-Asian |
1.456400E-01 |
| AfricanAmerican-vs-Asian |
8.865400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.18554080283684E-14 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
8.458400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(41-60Yrs) |
3.43058914609173E-14 |
| Normal-vs-Age(61-80Yrs) |
1.77535763867809E-12 |
| Normal-vs-Age(81-100Yrs) |
2.56210000004753E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.616400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.654800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.525000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.368600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.028360E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.586200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.87729999989728E-07 |
| Classical-VS-Follicular |
1.537350E-01 |
| Classical-VS-Other |
8.203800E-01 |
| Classical-VS-Normal |
1.62458935193399E-12 |
| Tall-VS-Follicular |
3.255300E-03 |
| Tall-VS-Other |
2.329400E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
7.922000E-01 |
| Follicular-VS-Normal |
8.37940827835837E-12 |
| Other-VS-Normal |
2.143600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.44089209850063E-16 |
| Normal-vs-N1 |
6.07625061377348E-13 |
| N0-vs-N1 |
4.159200E-01 |
|
|
